PD.pdf

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose:

NCATS is in need of a renewal of a subscription to access comprehensive drug database.

2. Background Information and Objective:

The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people’s health and save lives.

The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.

The NCATS Chemical Genomics Center (NCGC) is tasked with identifying and developing novel small molecule leads against a wide spectrum of human disease targets, which it accomplishes by screening thousands of small molecules in collaboration with both intra-and extramural researchers. In pursuit of this goal, the Center has a strong internal transdisciplinary team of scientists who continually discover novel small molecules for application against a wide range of human diseases.

The NCGC requires a renewal to its subscription to access a comprehensive database of information regarding drugs, investigational drugs and their mechanisms of action, pathway interaction, diseases, pharmacological data, and relevant patents. Through previous purchase history, this database provides reliable, detailed information across multiple disciplines to support successful drug research and development. The database is updated daily and contains information of 400 Annual Conferences, 11,000 peer reviewed journals, multiple global patent offices, and 5,500 + company and research institution reports. All this drug information is integrated in an easy-to-use database to enable scientist make earlier, more educated decisions.

3. Generic Name of Product: Annual renewal of comprehensive database of information on pharmaceuticals Software License

4. Purchase Description: One (1) Annual Software license to access a comprehensive database of information regarding drugs, diseases, pharmacological data, pathway interaction and relevant patents.

Integrity Internet Access 4 Users Metacore-Online Access 1 user Drugs of Today-Online Access 1 User Drugs of the Future-Online Access 1 User Drug News-Online Access 1 User

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

Salient characteristics:

1. Database shall be updated daily and shall draw information from the following sources:

o 400 Annual Conferences o 11,000 peer reviewed journals o multiple global patent offices o 5,500 + company and research institution reports

5. Quantity: 1 annual software license

6. Period of Performance: September 8, 2017 to September 7, 2018.